A detailed history of National Bank Of Canada transactions in A Ikido Pharma Inc. stock. As of the latest transaction made, National Bank Of Canada holds 176 shares of AIKI stock, worth $668. This represents 0.0% of its overall portfolio holdings.

Number of Shares
176
Previous 176 -0.0%
Holding current value
$668
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 12, 2023

BUY
$3.46 - $4.07 $608 - $716
176 New
176 $0

Others Institutions Holding AIKI

About AIkido Pharma Inc.


  • Ticker AIKI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,485,100
  • Market Cap $20.8M
  • Description
  • AIkido Pharma Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small mo...
More about AIKI
Track This Portfolio

Track National Bank Of Canada Portfolio

Follow National Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

News

Stay updated on National Bank Of Canada with notifications on news.